Latest Small Cap Feast
Small Cap Feast
Small Cap Feast – 05 June 2020
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
Castleton Technology has left AIM following a recommended cash takeover.
Castleton Technology has left AIM following a recommended cash takeover.
What’s Cooking in the IPO Kitchen?
The pantry is bare!
Applied Graphene Materials 11.8p £5.7m (AGM.L)
Exclusive distribution agreement with Dichem Polymers SA (Headquarters Acharnes, Greece). The agreement helps to extend AGM’s commercial reach directly into the coatings and polymers sectors across Greece.
Founded in 1977, Dichem Group, has a strong history of delivering high performance chemicals to a wide range of markets including cosmetics, pharmaceuticals, food industry, polymers and coatings. The company’s focus on supporting customers, with their specialist, technical focus, allows them the opportunity to actively participate in R&D programmes to establish new technologies in their selected sector.
Getech Group 16.5p £6.2m (GTC.L)
- Revenue £6.1 million (2018: £8.0 million), with new forward sales up 41% to c£2.4 million (2018: £1.7 million), a significant portion of which will unwind to revenue in 2020
- Orderbook increased by 48% to £3.1 million at 31 December 2019 (31 December 2018: £2.1 million)
- Annualised Recurring Revenue £2.3 million at 31 December 2019 (31 December 2018: £2.3 million)
- Total cost base 16% below 2018 (2019: £6.4 million; 2018: £7.6 million)
- Adjusted EBITDA £0.9 million (2018: £1.3 million), before exceptional items totalling £2.8 million
- Net cash £2.7 million at 31 December 2019 (31 December 2018: £0.5 million), with the Group generating free cash in H2-19
“We expect May’s sharp rebound in oil prices, which has continued into June, to take time to filter through to our customer conversations. Getech’s revenue is normally weighted 40:60 between H1 and H2 and there is the likelihood this weighting becomes accentuated into H2 in 2020. In H1 2020 we have focused on the replenishment of our orderbook and protecting annually recurring revenue. Year-to-date, we are cautiously encouraged by the renewal rate across our software products and we have won service extensions that deliver monthly revenue to year-end. We are also negotiating various licence renewals to our Globe knowledge product.”
C4X Discovery 15.6p £18.6m (C4XD.L)
Clive Dix, Chief Executive Officer of C4XD has been appointed a member and Deputy Chair of the Steering Board of the UK Vaccine Taskforce, the group set up by the Government’s Chief Scientific Adviser, Deputy Chief Medical Officer, Business Secretary and Health Secretary to lead UK efforts to find and manufacture a COVID-19 vaccine. Clive remains committed to delivering C4XD’s strategy and this appointment will not impact his day-to-day role as CEO.
Block Energy 2.1p £8.3m (BLOE.L)
The current Technical Director, Roger McMechan, has stepped back from his executive position to pursue his other interests with effect from 3 June. Roger will continue on the Board as a non-executive director, enabling the Company to utilise his petroleum engineering expertise and detailed knowledge of the Company’s assets as Block Energy prepares to restart oil production and initiate gas production at its West Rustavi field.
The Company welcomes Ritchie Wayland as Technical Manager. Ritchie holds a Master’s degree in petroleum geology from Imperial College London. He started his career with Schlumberger, working as a wellsite logging engineer in the Middle East, North Africa, the Caribbean and Australia. On leaving Imperial College and BP, he joined Phillips Petroleum, to work in the UK and West Africa, initially as a project geologist before leading sub-surface teams, where he specialised in the development of team performance by integrating the contributions of commercial, operations and subsurface staff to successfully discover and develop several new fields.
GYG 74.5p £34.75m (GYG.L)
The market leading superyacht painting, supply and maintenance company, announced the signing of two Refit contracts with MB92 Group. These two contracts, with a combined value of over EUR6 million, are due to commence immediately in MB92 Group’s specialist facilities in Barcelona, Spain and La Ciotat, France. GYG’s operations in both shipyards are running as normal, with enhanced health and safety protocols in place, following a short closure of the yards during March and April.
Thor Mining* 0.4p £4.3m (THR.L)
Commencement of field activities associated with the due diligence assessment for the acquisition of American Vanadium Pty Ltd (AVU) , which holds interests in uranium and vanadium focussed projects in Colorado and Utah in the United States of America. The Company announced on 1 June 2020 an option agreement to acquire AVU, subject to satisfaction of due diligence requirements.
In addition, investigations to date, while not yet complete, have revealed no regulatory or environmental issues which would cast doubt on the transaction. Some historical data has been obtained, allowing a preliminary understanding of some potential opportunities.
- The Thor team based in Colorado has commenced field due diligence activities consisting of site reviews and sampling from historical mines around the Wedding Bell and Radium Mountain.
- Historical data reviews show substantial previous mining activity in the western portion of the Wedding Bell claims (Colorado), with the geology trending into the untested eastern portion of the claims.
- At the Utah Claims, located approximately 40km north of the town of Moab, 1980’s drilling reported significant uranium and vanadium mineralisation from within the Brushy Basin Member of the Jurassic Morrison Formation, however the deeper and normally higher grade Salt Wash Member remains substantially untested.
- Anecdotal reports suggest that historical mining practices in the region often selectively recovered high grade material, leaving vanadium rich mineralisation, above and/or below the uranium rich zones.
- Sampling and field based activities are expected to continue for the next week, with results planned to be released later this month.
IGas Energy 26p £31.9m (IGAS.L)
AGM Statement. “Reflecting on our 2019 results, we continued to deliver on our strategic priorities and set about further reducing our financing costs through a $40 million Reserve Based Lending facility (RBL), which was secured in October 2019. I am pleased to announce today that we have successfully completed the RBL redetermination (a semi-annual recalculation), confirming US$29 million (£23.3 million) of debt capacity and current headroom of US$13 million (£10.5 million).
Operationally, in 2019, we delivered production well within guidance, made progress in advancing incremental production projects and made a potentially world-class discovery at our Springs Road well site.
As is well documented, the early part of 2020 has been a turbulent one for not only this industry, but for each and every one of us. We have had to re-evaluate short term priorities to weather the oil price disruption and COVID-19 impacts.
As announced on 1 May, we took the prudent decision to temporarily shut-in a number of sites during May and June, which will have a positive impact on our cash flow during these two months of c.£500k and will reduce production by c.600 boepd for this period. We have accessed the Government’s Job Retention Scheme with approximately 40 employees currently placed on furlough. We continue to review the number of shut-in sites on a regular basis and we will monitor the oil price and the furlough scheme to see when production should be restarted.”
Metal Tiger 2.33p £35m (MTR.L)
Metal Tiger has executed an International Swaps and Derivatives Association (agreement and Credit Support Annex with the same global investment bank with which it has the equity derivative financing arrangements subject to the Umbrella Agreement, as announced on 17 December 2019.
The execution of the ISDA agreement will allow Metal Tiger to obtain access to over-the-counter (“OTC”) derivatives including but not limited to equities, commodities and FX contracts.
The CSA essentially helps to stipulate the terms and conditions under which each party is required to post collateral to each other.
Cadence Minerals 11.75p £14.12m (KDNC.L)
Macarthur Minerals (TSX-V: MMS) Joint Venture Partner, Fe Limited has announced the completion of the sale of its Evanston royalty interest over a portion of the wider Koolyanobbing iron ore mine in the Southern Yilgarn region of Western Australia.
TRR Services Australia Pty Ltd, a wholly owned subsidiary of Trident Resources PLC (LSX: TRR), has purchased the royalty for $7 million. FEL has received the first payment of $3.5 million with a further instalment of $3m payable in 12 months. FEL now has cash in the bank of $5.2 million and fully funded to commence exploration work at the Hillside Copper and Gold Project in the Pilbara region of Western Australia.
FEL is currently finalising plans to conduct a Fixed Loop Electromagnetic Survey (FLEM) ground survey at the Hillside project.
Trans Siberian Gold 88.5p £77.14m (TSG.L)
Low cost, high grade gold producer in Kamchatka, Russia, is pleased to confirm that the Company’s wholly owned subsidiary AO Trevozhnoye Zarevo (“TZ”) has entered into an agreement with PJSC VTB Bank (“VTB”) for a revolving credit line with a limit of $10 million for a period of 3 years.
This agreement, successfully re-finances an existing credit line with a limit of $5 million expiring on 20 June 2020 and enhances the short-term liquidity of the Group. The existing facility has been fully repaid. TZ currently has not drawn down any funds under the new credit facility.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.